Closed · CDC-RFA-GH15-1603 · CFDA 93.067 · Discretionary
Strengthening Clinical and Laboratory Services at the National Referral Level to Improve HIV Prevention, Care, and Treatment in the Republic of Zambia under the President's Emergency Plan for AIDS Relief (PEPFAR)
Federal grant opportunity posted by Centers for Disease Control and Prevention, cataloged on Grants.gov.
- $5.5M-$27.5M
- Award range
- Closed
- Status
- January 23, 2015
- Close date
- 1
- Expected awards
The verdict
Strengthening Clinical and Laboratory Services at the National Referral Level to Improve HIV Prevention, Care, and Treatment in the Republic of Zambia under the President's Emergency Plan for AIDS Relief (PEPFAR) is a closed discretionary listing from Centers for Disease Control and Prevention that offered $5,495,000 -- $27,475,000 across 1 expected award. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,727 other opportunities from Centers for Disease Control and Prevention.
- $5.5M-$27.5M
- award range
- Closed
- application status
- 1
- expected award
- 93.067
- CFDA program
Archived opportunity record
Strengthening Clinical and Laboratory Service… is closed (last close January 23, 2015). The parent program page for CFDA 93.067 is the reliable place to catch re-announcements. Centers for Disease Control and Prevention still indexes 1,727 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed January 23, 2015
Est. Total Funding
$5,495,000
Expected Awards
1
Instrument
Cooperative Agreement
Description
1. CDC Project Description a. Approach: ActivitiesOutcomesShort Term Outcomes (1-2 Years)Intermediate Outcomes (3-4 Years)Long Term Outcomes(5+ Years)CARE AND TREATMENT OF HIV INFECTED PERSONSProvide comprehensive clinical management of HIV infected persons including screening and treatment for TB, sexually transmitted infections (STIs) and opportunistic infections (OIs) and antiretroviral therapy (ART) for treating eligible persons Evaluate HIV disease stage and initiate ART for all HIV infected persons who meet national eligibility criteria Perform TB syndromic screening of HIV patients, followed by laboratory confirmation and TB treatment, as needed, and provide Isoniazid prophylaxis to TB screen negative patients Provide cotrimoxazole (CTX) prophylaxis to HIV infected persons, according to national guidelines Evaluate HIV patients for STIs or OIs and treat as needed Strengthen linkages for patient referrals within the host facility and to named primary care facilities by providing quarterly lists of referred patients to sites and requesting feedback on referral outcome and retention of patients on ARTIncreased number of HIV infected children initiated on ART Increased number of adults initiated on ARTIncreased uptake of ART initiation among HIV infected persons Increased number of HIV infected persons appropriately managed and treated for TB, STIs and OIsImproved virological suppression among HIV infected persons receiving appropriate clinical management and treatment Increased retention of patients on ARTMonitor the impact of ART on individuals through viral load (VL) testing and HIV drug resistance testing for those with suspected treatment failure Implement viral load (VL) testing for all persons on ART at 6 months and 12 months, and annually thereafter, and use VL test results to adjust treatment regimens, according to national guidelines Implement HIV drug resistance (DR) testing of patients with suspected ART treatment failureIncreased number of HIV infected persons on ART with VL results available according to schedule Increased number of persons with suspected treatment failure with available HIV DR test resultsIncreased number of persons with suspected ART treatment failure on appropriate anti-retroviral (ARV) treatment regimen based on HIV DR resultsIncreased use of effective ARV treatment regimens that lead to viral suppressionProvide nutritional counseling, as appropriate, to HIV infected persons and their familiesIncreased number of HIV infected persons receiving nutritional advice and managementReduced morbidity due to nutritional deficiencies among HIV infected persons and their familiesReduced morbidity due to nutritional deficiencies among HIV infected persons and their familiesAssist MOH to strengthen skills of clinicians and develop guidelines to improve care and treatment of HIV/AIDS patientsIncreased number of clinicians mentored in other health care facilities by Partner’s staff Increased number of provinces with newly established Advanced HIV Treatment Centers to manage complicated HIV cases e.g. patients failing second line therapy, needing HIV DR testing to guide selection of ART regimen, or, with complicated co-morbidities (e.g. with advanced cardiac failure and end stage renal failure)Increased number of HIV infected persons appropriately managed and treatedImproved virological suppression among HIV infected persons receiving appropriate clinical management and treatment Increased retention of patients on ART Continued under..2. CDC Project Description
Catch-all / unrestricted eligibility mark · CDC-RFA-GH15-1603
Grants.gov marks Strengthening Clinical and Laboratory Service… with a catch-all / unrestricted eligibility code (Others (see official listing text)). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity code maps to Health (HL). This eligibility-code string dominates the Centers for Disease Control and Prevention book (1,452 peers, 84% of 1,728).
- Code 25
- Others (see official listing text)
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Parent Grant Program
Global AIDS
U.S. Department of Health and Human Services
Agency Contact
OGSTIMS
More from Centers for Disease Control and Prevention
What to do next
Strengthening Clinical and Laboratory Service… is closed; use the parent program and agency catalog for the next funding cycle.
- Parent CFDA 93.067 may publish future NOFOs under the same assistance listing. Open program
- Global AIDS indexes 2 Grants.gov listings in this extract. Program profile
- Centers for Disease Control and Prevention lists 1,727 other indexed opportunities on PlainGrants. Agency catalog
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |